Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)
Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 68788-8367
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 68788-8367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)
This is a graph depicting the concentration of Tramadol, a pain medication, in ng/mL over time (in hours). The graph compares the concentration levels of Tramadol Hydrochloride Extended-Release Tablets (at a dose of 200 mg once a day) and Tramadol Hydrochloride Tablets (at a dose of 50 mg every 6 hours).*
Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)
This is a graph showing the concentration of M1 (in ng/mL) over time (in hours) for two different types of Tramadol medications: Extended-Release Tablets (200mg q.d.) and Regular Tablets (50mg g6h). The concentration of M1 is plotted on the y-axis and time is plotted on the x-axis.*
Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)
This appears to be a graph showing the percentage of patients achieving various levels of response threshold for four different doses of Tramadol Hydrochloride Extended-Release Tablets and a placebo. The x-axis shows the response threshold in percent improvement from baseline, while the y-axis shows the percentage of patients achieving that threshold. The four doses of Tramadol Hydrochloride Extended-Release Tablets are 100mg, 200mg, 300mg, and 400mg. The graph also includes a WOMAC Pain Responder Analysis.*
Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)
This is a study analysis of patients with arthritis pain intensity who were prescribed Tramadol Hydrochloride Extended-Release Tablets. The study, referred to as Study 015, evaluated the percentage of patients achieving different levels of response thresholds in comparison to a placebo. The results are presented in a graph that shows the percentage of patients achieving a response threshold based on the percentage of improvement from baseline.*
Tramadol Hydrochloride Er Tablets 100mg (C30f6e9e 8014 40fc 9615 A6b8654137c1 00)
Tramadol Hydrochloride ER Tablets 100mg (CIV) is a medication that should only be transferred to the individual who was prescribed this drug. It is a generic form of Ultram ER and is produced by Lupin Pharmaceuticals, Inc. The tablets are round, white, and imprinted with LO10. It contains 100mg of tramadol hydrochloride, USP. The tablets should be swallowed whole with liquid and not split, chewed, dissolved, or crushed. This medication should be kept out of reach of children, and excursions permitted between 15°. The expiration date is 25 gm0. This text seems to be a label or packaging material for Tramadol Hydrochloride ER Tablets 100mg (CIV).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
